Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In the DURATION-8 trial, dapagliflozin as monotherapy and in combination with EX-QW showed trends favoring improvements in LFC, glucose and lipid metabolism, and liver fibrosis scores at the end of the study, but no significant statistical differences were observed
ISSN 1354-3776
They can help monitor how your body is adjusting and make changes to your treatment plan if needed to keep things on track
The documentation should reflect the clinical reality of why your provider is prescribing it
US$ 26.02
US$ 21.20
US$ 24.37
US$ 26.42
US$ 25.65
